The Pharma Data

DECEMBER 14, 2020

FDA Approves Genetically Engineered Pigs for Food, Possible Medical Use. 14, 2020 — The first genetically engineered pigs for use as food or for potential future biomedical use — such as transplantation — in humans have been approved by the U.S. Professional. MONDAY, Dec.

Genetic Engineering 52

Genetic Engineering Engineer FDA Approval Genetics 52

Pharmaceutical Technology

APRIL 5, 2023

It will be six years since the US FDA approval of Kymriah in August this year. Bruce Levine [BL]: We now have six approved CAR-T therapies. That’s not to say that we couldn’t have some approvals coming next year or the year after that for allogeneic therapies. How has the field changed in recent years?

Gene Therapy 147

Gene Therapy Gene Engineer Production 147

Advarra

AUGUST 8, 2023

As of June 2023, 416 Phase III studies are listed, representing a growing pipeline of gene therapy products preparing to undergo consideration for FDA approval. Risks and Regulatory Requirements Most clinical researchers are familiar with the regulatory requirements pertaining to the FDA phases of review as well as with IRB review.

Gene Therapy 52

Gene Therapy Gene Research Genetics 52

pharmaphorum

SEPTEMBER 13, 2022

Just over a decade after it was developed by biochemist Nicholas Lyndon, Imatinib received US Food and Drug Administration (FDA) approval in 2001. Over the past few years, the number of treatments approved for blood cancer has skyrocketed. 2002 – Emergence of CAR-T therapy. 2012 – The 100,000 Genomics Project begins.

Genome Project 98

Genome Project Genomics Genome DNA 98

XTalks

MARCH 6, 2024

This includes discussions on cutting-edge technologies and methodologies in brain research, such as neuroimaging, genetic engineering and artificial intelligence. Boston Scientific’s Deep Brain Stimulation (DBS) Software received FDA approval last year for the treatment of Parkinson’s disease and essential tremor.

FDA Approval 69

FDA Approval In-Vitro Research Marketing 69

Advarra

JANUARY 11, 2024

Some of these approaches involve directly isolating the patient’s immune cells and simply expanding their quantity, while other treatments involve genetically engineering their immune cells to enhance cancer-fighting capabilities.

Vaccination 52

Vaccination Vaccine Protein Antibody 52

The Pharma Data

NOVEMBER 9, 2020

is a leading innovator of recombinant vaccines; its proprietary recombinant technology platform combines the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles in order to address urgent global health needs. NVX-CoV2373 (SARS-CoV-2 vaccine) FDA Approval History. Source link.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52